Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 76.81%122.72M | 2.80%449.52M | 13.23%124.04M | -0.61%88.43M | 13.31%135.53M | -41.75%69.41M | 0.67%437.27M | -20.78%109.54M | -20.82%88.97M | 55.59%119.61M |
| Cost of revenue | 125.94%92.91M | -4.66%323.46M | -0.68%85.52M | 2.17%69.11M | 10.63%104.65M | -54.78%41.12M | 13.90%339.26M | -1.96%86.1M | -16.35%67.65M | 96.80%94.59M |
| Gross profit | 5.38%29.81M | 28.62%126.06M | 64.31%38.52M | -9.43%19.31M | 23.43%30.89M | 0.23%28.29M | -28.20%98.01M | -53.54%23.44M | -32.30%21.32M | -13.16%25.02M |
| Operating expense | -5.04%13.51M | -1.20%60.61M | 148.59%18.24M | 0.35%13.66M | -1.89%15.82M | -9.76%14.22M | -10.88%61.35M | -282.38%-37.54M | -19.23%13.62M | 4.01%16.12M |
| Selling and administrative expenses | -0.20%15.4M | 0.50%67.01M | 2.29%18.55M | 5.28%15.66M | 3.91%17.5M | -8.30%15.43M | -7.15%66.67M | -15.28%18.13M | -16.60%14.87M | 3.25%16.85M |
| -Selling and marketing expense | -12.00%1.2M | -9.13%6.25M | -31.61%1.49M | -0.89%1.45M | 10.55%1.95M | -7.57%1.37M | -12.39%6.88M | -5.75%2.18M | -25.60%1.46M | -10.60%1.76M |
| -General and administrative expense | 0.95%14.19M | 1.61%60.75M | 6.93%17.06M | 5.95%14.21M | 3.13%15.55M | -8.37%14.06M | -6.51%59.79M | -16.43%15.95M | -15.49%13.42M | 5.16%15.08M |
| Other operating expenses | ---- | 2,472.55%1.31M | ---- | ---- | ---- | ---- | -50.96%51K | ---- | ---- | ---- |
| Total other operating income | 56.98%1.89M | 43.32%7.71M | -99.44%309K | 58.54%2M | 133.56%1.68M | 13.37%1.2M | 74.59%5.38M | 5,931.09%55.67M | 28.73%1.26M | -11.21%721K |
| Operating profit | 15.93%16.31M | 78.50%65.45M | -66.74%20.28M | -26.70%5.65M | 69.31%15.07M | 12.87%14.07M | -45.82%36.67M | 104.08%60.98M | -47.35%7.71M | -33.15%8.9M |
| Net non-operating interest income (expenses) | 26.65%-5.52M | -24.78%-28.86M | -0.92%-6.62M | 19.43%-4.6M | 5.06%-5.07M | -35.88%-7.52M | 6.55%-23.13M | -16.18%-6.56M | 7.19%-5.7M | 14.10%-5.34M |
| Non-operating interest income | -28.52%634K | 46.63%5.77M | 68.79%2.39M | 99.60%1.49M | -7.07%920K | -10.67%887K | 44.19%3.94M | 20.56%1.41M | 29.12%745K | 55.17%990K |
| Non-operating interest expense | -26.84%6.15M | 29.05%32.66M | 12.95%9M | -5.68%6.08M | -5.37%5.99M | 28.80%8.41M | -5.47%25.31M | 30.54%7.97M | -4.08%6.45M | -7.65%6.33M |
| Total other finance cost | ---- | 12.23%1.97M | ---- | ---- | ---- | ---- | 147.61%1.76M | ---- | ---- | ---- |
| Net investment income | -28.62%2.52M | -36.98%3.53M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 4.95%911K | 105.96%4.74M | -118.04%-605K | 155.22%2.86M | -28.46%3.08M | -58.01%868K | -852.29%-79.61M | 365.83%3.35M | -68.62%1.12M | -23.48%4.3M |
| Special income (charges) | -104.39%-6.06M | 2,960.37%138.21M | ||||||||
| Less:Restructuring and mergern&acquisition | ---- | 100.92%1.26M | ---- | ---- | ---- | ---- | -30,004.79%-137.26M | ---- | ---- | ---- |
| Less:Impairment of capital assets | ---- | --16K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Less:Other special charges | ---- | ---373K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | ---- | 642.84%5.16M | ---- | ---- | ---- | ---- | -121.70%-950K | ---- | ---- | ---- |
| Other non-operating income (expenses) | 2.10%2.14M | 16.03%2.09M | ||||||||
| Income before tax | 57.84%11.7M | -48.66%39.92M | -77.39%13.06M | 25.28%3.92M | 66.31%13.08M | -17.58%7.41M | 38.69%77.76M | 109.91%57.78M | -74.10%3.13M | -38.18%7.86M |
| Income tax | 12.07%3.23M | 57.01%14.56M | 56.89%5.14M | 3,628.33%2.12M | 101.60%4.42M | -25.39%2.88M | -46.06%9.27M | -61.27%3.28M | -101.89%-60K | -41.86%2.19M |
| Net income | 86.97%8.47M | -62.97%25.36M | -85.47%7.92M | -43.55%1.8M | 52.69%8.66M | -11.70%4.53M | 76.17%68.49M | 185.91%54.5M | -64.19%3.19M | -36.64%5.67M |
| Net income continuous operations | 86.97%8.47M | -62.97%25.36M | -85.47%7.92M | -43.55%1.8M | 52.69%8.66M | -11.70%4.53M | 76.17%68.49M | 185.91%54.5M | -64.19%3.19M | -36.64%5.67M |
| Noncontrolling interests | 46.17%2.37M | 223.51%6.52M | 26.12%1.32M | 0 | 109.74%797K | 375.07%1.62M | -52.78%2.02M | -68.01%1.05M | 35.87%250K | -10.38%380K |
| Net income attributable to the company | 109.69%6.1M | -71.66%18.84M | -87.65%6.6M | -38.74%1.8M | 48.59%7.87M | -39.24%2.91M | 92.08%66.47M | 238.44%53.46M | -66.30%2.94M | -37.94%5.29M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 109.69%6.1M | -71.66%18.84M | -87.65%6.6M | -38.74%1.8M | 48.59%7.87M | -39.24%2.91M | 92.08%66.47M | 238.44%53.46M | -66.30%2.94M | -37.94%5.29M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 109.91%0.0091 | -71.67%0.0281 | -87.66%0.0099 | -38.81%0.0027 | 48.61%0.0117 | -39.30%0.0043 | 91.88%0.0992 | 237.89%0.0798 | -66.31%0.0044 | -37.94%0.0079 |
| Diluted earnings per share | 109.91%0.0091 | -71.67%0.0281 | -87.66%0.0099 | -38.81%0.0027 | 48.61%0.0117 | -39.30%0.0043 | 91.88%0.0992 | 237.89%0.0798 | -66.31%0.0044 | -37.94%0.0079 |
| Dividend per share | 0 | 0.00%0.02 | 0 | 0 | 0 | 0.02 | 0.00%0.02 | 0 | 0 | 0.00%0.02 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.